...
search icon
amph-img

Amphastar P, Common Stock

AMPH

NSQ

$24.41

+$0.22

(0.91%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.12B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
7.9052
Volume info-icon
This is the total number of shares traded during the most recent trading day.
355.52K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.79
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$22.64 L
$53.95 H
$24.41

About Amphastar P, Common Stock

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging, as well as Albuterol Sulfate inhalation aerosol. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameAMPHSectorS&P500
1-Week Return3.87%4.13%7.14%
1-Month Return-14.14%-4.48%-0.92%
3-Month Return-34.24%-5.78%-8.95%
6-Month Return-52.52%-7.23%-5.21%
1-Year Return-41.91%-1.69%7.95%
3-Year Return-31.1%3.23%28.74%
5-Year Return42.58%38.7%92.67%
10-Year Return63.17%88.08%161.14%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue349.85M437.77M498.99M644.39M712.81M[{"date":"2020-12-31","value":49.08,"profit":true},{"date":"2021-12-31","value":61.41,"profit":true},{"date":"2022-12-31","value":70,"profit":true},{"date":"2023-12-31","value":90.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue206.51M238.03M250.13M293.27M338.96M[{"date":"2020-12-31","value":60.92,"profit":true},{"date":"2021-12-31","value":70.22,"profit":true},{"date":"2022-12-31","value":73.79,"profit":true},{"date":"2023-12-31","value":86.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit143.34M199.74M248.86M351.12M373.86M[{"date":"2020-12-31","value":38.34,"profit":true},{"date":"2021-12-31","value":53.43,"profit":true},{"date":"2022-12-31","value":66.57,"profit":true},{"date":"2023-12-31","value":93.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin40.97%45.63%49.87%54.49%52.45%[{"date":"2020-12-31","value":75.19,"profit":true},{"date":"2021-12-31","value":83.74,"profit":true},{"date":"2022-12-31","value":91.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.25,"profit":true}]
Operating Expenses132.39M129.85M141.36M154.13M168.44M[{"date":"2020-12-31","value":78.6,"profit":true},{"date":"2021-12-31","value":77.09,"profit":true},{"date":"2022-12-31","value":83.93,"profit":true},{"date":"2023-12-31","value":91.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(14.23M)43.13M78.76M196.99M205.42M[{"date":"2020-12-31","value":-6.93,"profit":false},{"date":"2021-12-31","value":21,"profit":true},{"date":"2022-12-31","value":38.34,"profit":true},{"date":"2023-12-31","value":95.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(6.05M)13.97M8.02M(40.12M)(35.39M)[{"date":"2020-12-31","value":-43.31,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":57.4,"profit":true},{"date":"2023-12-31","value":-287.24,"profit":false},{"date":"2024-12-31","value":-253.34,"profit":false}]
Pre-Tax Income4.64M84.14M116.04M171.36M189.76M[{"date":"2020-12-31","value":2.44,"profit":true},{"date":"2021-12-31","value":44.34,"profit":true},{"date":"2022-12-31","value":61.15,"profit":true},{"date":"2023-12-31","value":90.3,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes3.54M20.63M23.48M31.83M29.67M[{"date":"2020-12-31","value":11.12,"profit":true},{"date":"2021-12-31","value":64.81,"profit":true},{"date":"2022-12-31","value":73.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":93.21,"profit":true}]
Income After Taxes1.10M63.51M92.56M139.53M160.09M[{"date":"2020-12-31","value":0.69,"profit":true},{"date":"2021-12-31","value":39.67,"profit":true},{"date":"2022-12-31","value":57.82,"profit":true},{"date":"2023-12-31","value":87.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations1.10M63.51M91.39M135.29M159.52M[{"date":"2020-12-31","value":0.69,"profit":true},{"date":"2021-12-31","value":39.81,"profit":true},{"date":"2022-12-31","value":57.29,"profit":true},{"date":"2023-12-31","value":84.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income1.10M62.12M91.39M137.54M159.52M[{"date":"2020-12-31","value":0.69,"profit":true},{"date":"2021-12-31","value":38.94,"profit":true},{"date":"2022-12-31","value":57.29,"profit":true},{"date":"2023-12-31","value":86.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)0.641.361.973.303.86[{"date":"2020-12-31","value":16.58,"profit":true},{"date":"2021-12-31","value":35.23,"profit":true},{"date":"2022-12-31","value":51.04,"profit":true},{"date":"2023-12-31","value":85.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AMPH
Cash Ratio 1.28
Current Ratio 3.07
Quick Ratio 2.19

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AMPH
ROA (LTM) 8.31%
ROE (LTM) 23.26%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AMPH
Debt Ratio Lower is generally better. Negative is bad. 0.54
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.46

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AMPH
Trailing PE 7.90
Forward PE NM
P/S (TTM) 1.58
P/B 1.58
Price/FCF 70
EV/R 2.17
EV/Ebitda 5.73
PEG 2.77

FAQs

What is Amphastar P share price today?

Amphastar P (AMPH) share price today is $24.41

Can Indians buy Amphastar P shares?

Yes, Indians can buy shares of Amphastar P (AMPH) on Vested. To buy Amphastar P from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AMPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Amphastar P be purchased?

Yes, you can purchase fractional shares of Amphastar P (AMPH) via the Vested app. You can start investing in Amphastar P (AMPH) with a minimum investment of $1.

How to invest in Amphastar P shares from India?

You can invest in shares of Amphastar P (AMPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in AMPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Amphastar P shares
What is Amphastar P 52-week high and low stock price?

The 52-week high price of Amphastar P (AMPH) is $53.95. The 52-week low price of Amphastar P (AMPH) is $22.64.

What is Amphastar P price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Amphastar P (AMPH) is 7.9052

What is Amphastar P price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Amphastar P (AMPH) is 1.58

What is the Market Cap of Amphastar P?

The market capitalization of Amphastar P (AMPH) is $1.12B

What is Amphastar P’s stock symbol?

The stock symbol (or ticker) of Amphastar P is AMPH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top